| |
Original Artikel |
Journal |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
Biochemical Society Transactions |
2024―Sep―02 |
Human E3 ubiquitin ligases: accelerators and brakes for SARS-CoV-2 infection |
Jesse Pellman, Anna Goldstein, Mikołaj Słabicki |
| 2 |
[GO] |
Bioscience Reports |
2024―Jul―24 |
Boosting Immunity: Synergistic Antiviral Effects of Luteolin, Vitamin C, Magnesium, and Zinc Against SARS-CoV-2 3CLpro |
Juliana C. Ferreira, Samar Fadl, Thyago H. S. Cardoso, Bruno Andrade, Tarcisio S. Melo, Edson M.A. Silva, Anupriya Agarwal, Stuart Turville, Nitin K. Saksena, Wael M. Rabeh |
| 3 |
[GO] |
Bioscience Reports |
2024―Jul―22 |
3C-like proteases in SARS-CoV-2 |
Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, Samar Fadl, Farah El-Sadaany, Imen Masmoudi, Yugmee Gidiya, Tariro Gurudza, Thyago H. S. Cardoso, Nitin K. Saksena, Wael M. Rabeh |
| 4 |
[GO] |
Biochemical Journal |
2024―Mai―07 |
Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in Escherichia coli |
Emma L Brudenell, Manoj B Pohare, Domen Zafred, Janine Phipps, Hailey R Hornsby, John Darby, Junxiao Dai, Ellen Liggett, Kathleen Cain, Perdita Barran, Thushan I de Silva, Jon R Sayers |
| 5 |
[GO] |
Clinical Science |
2024―Apr―04 |
Correction: The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease |
|
| 6 |
[GO] |
Clinical Science |
2024―Feb―19 |
COVID-19 and abnormal uterine bleeding: potential associations and mechanisms |
Jacqueline A. Maybin, Marianne Watters, Bethan Rowley, Catherine A. Walker, Gemma C. Sharp, Alexandra Alvergne |
| 7 |
[GO] |
Bioscience Reports |
2023―Dez―22 |
SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-κB activation |
Marie J Tofaute, Benjamin Weller, Carina Graß, Hridi Halder, Bushra Dohai, Pascal Falter-Braun, Daniel Krappmann |
| 8 |
[GO] |
Biochemical Society Transactions |
2023―Dez―18 |
Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection |
Debjit Khan, Paul L. Fox |
| 9 |
[GO] |
Biochemical Journal |
2023―Aug―16 |
Are fibrinaloid microclots a cause of autoimmunity in Long Covid and other post-infection diseases? |
Douglas B. Kell, Etheresia Pretorius |
| 10 |
[GO] |
Bioscience Reports |
2023―Jul―27 |
Surfactant Replacement Therapy as Promising Treatment for COVID-19: an Updated Narrative Review |
Khaled Kh�h, Alaa Ramadan, Ahmed Othman, Neveen Refaey, Amr Alrosasy, Ayoub Rezkallah, Toka Heseba, Mostafa Hossam El Din Moawad, Ammar Mektebi, Sewar A Elejla, Mohamed Abouzid, Basel Abdelazeem |
| 11 |
[GO] |
Bioscience Reports |
2023―Jul―24 |
The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy |
Abdulla Abu-Bakr Badawy |
| 12 |
[GO] |
Biochemical Society Transactions |
2023―Jun―09 |
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence |
Xiyuan Bai, Tony Schountz, Ashley M. Buckle, Janet L. Talbert, Robert A. Sandhaus, Edward D. Chan |
| 13 |
[GO] |
Biochemical Journal |
2023―Mai―31 |
Key Allosteric and Active Site Residues of SARS-CoV-2 3CLpro Are Promising Drug Targets |
Kenana Al Adem, Juliana C. Ferreira, Samar Fadl, Morad Mustafa, Wael M. Rabeh |
| 14 |
[GO] |
Bioscience Reports |
2023―Mai―22 |
COVID-19 Associated Thyroid Dysfunction and Other Comorbidities and Its Management Using Phytochemical-Based Therapeutics- A Natural Way |
Arpana Parihar, Shivani Malviya, Raju Khan, Ajeet Kaushik, Ebrahim Mostafavi |
| 15 |
[GO] |
Biochemical Society Transactions |
2023―Mai―18 |
Mechanisms of impairment of interferon production by SARS-CoV-2 |
Huy-Dung Hoang, Parisa Naeli, Tommy Alain, Seyed Mehdi Jafarnejad |
| 16 |
[GO] |
Bioscience Reports |
2023―Mrz―06 |
Acid-Base Imbalance as a Risk Factor for Mortality among COVID-19 Hospitalized Patients |
Nosayba Al-Azzam, Basheer Khassawneh, Sayer Al-Azzam, Reema Karasneh, Mamoon A Aldeyab |
| 17 |
[GO] |
Bioscience Reports |
2023―Jan―18 |
Polypharmacology of ambroxol in the treatment of COVID-19 |
Ziyuan Wang, Minghui Yang, Xi Chen, Rongxin Xiao, Yu Dong, Ming Chu, Guojie Song, Yuedan Wang |
| 18 |
[GO] |
Biochemical Society Transactions |
2022―Nov―24 |
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination |
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O'Hehir, Menno C. van Zelm |
| 19 |
[GO] |
Clinical Science |
2022―Nov―11 |
Vascular dysfunction in COVID-19 patients: update on SARS-CoV-2 infection of endothelial cells and the role of long non-coding RNAs |
Jaroslav Pelisek, Benedikt Reutersberg, Urs F Greber, Alexander Zimmermann |
| 20 |
[GO] |
Clinical Science |
2022―Okt―21 |
Therapeutic use of calpeptin in COVID-19 infection |
Jameel Inal, Ainura Paizuldaeva, Esmeralda Terziu |
| 21 |
[GO] |
Biochemical Journal |
2022―Okt―07 |
Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2 |
Cameron Lee Shetler, Juliana C. Ferreira, Thyago H. S. Cardoso, Edson M.A. Silva, Nitin K. Saksena, Wael M. Rabeh |
| 22 |
[GO] |
Biochemical Journal |
2022―Sep―02 |
The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications |
Douglas B. Kell, Etheresia Pretorius |
| 23 |
[GO] |
Clinical Science |
2022―Jul―06 |
Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection |
Erin B. Taylor |
| 24 |
[GO] |
Biochemical Journal |
2022―Apr―05 |
Development of a colorimetric assay for the detection of SARS-CoV-2 3CLpro activity |
Gavin D Garland, Robert F Harvey, Thomas E Mulroney, Mie Monti, Stewart Fuller, Richard Haigh, Pehuén Pereyra Gerber, Michael R Barer, Nicholas J Matheson, Anne E Willis |
| 25 |
[GO] |
Clinical Science |
2022―Mrz―29 |
SARS-CoV-2 spike protein causes cardiovascular disease independent of viral infection |
John D. Imig |
| 26 |
[GO] |
Biochemical Journal |
2022―Mrz―04 |
Programmed cell death: the pathways to severe COVID-19? |
Stefanie M. Bader, James P. Cooney, Marc Pellegrini, Marcel Doerflinger |
| 27 |
[GO] |
Biochemical Journal |
2022―Feb―23 |
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications |
Douglas B. Kell, Gert Jacobus Laubscher, Etheresia Pretorius |
| 28 |
[GO] |
Biochemical Society Transactions |
2022―Jan―11 |
Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases |
Anoop Narayanan, Shay A. Toner, Joyce Jose |
| 29 |
[GO] |
The Biochemist |
2021―Dez―16 |
A pandemic in the age of next-generation sequencing |
Angela H. Beckett, Kate F. Cook, Samuel C. Robson |
| 30 |
[GO] |
Clinical Science |
2021―Dez―08 |
Erythrocytes increase endogenous sphingosine 1-phosphate (S1P) levels as an adaptive response to SARS-CoV-2 infection |
Martin Sebastian Winkler, Ralf A Claus, Mareike Schilder, Stefan Pöhlmann, Sina Coldewey, Julian Grundmann, Torben Fricke, Onnen Moerer, Konrad Meissner, Michael Bauer, Heike Hofmann-Winkler, Markus Gräler |
| 31 |
[GO] |
Biochemical Society Transactions |
2021―Dez―02 |
The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines |
Kensaku Murano, Youjia Guo, Haruhiko Siomi |
| 32 |
[GO] |
Clinical Science |
2021―Nov―22 |
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease |
Elisa Avolio, Michele Carrabba, Rachel Milligan, Maia Kavanagh Williamson, Antonio Beltrami, Kapil Gupta, Karen T Elvers, Monica Gamez, Rebecca Foster, Kathleen Gillespie, Fergus Hamilton, David Arnold, Imre Berger, Andrew Davidson, Darryl J. Hill, Massimo Caputo, Paolo Madeddu |
| 33 |
[GO] |
Biochemical Journal |
2021―Sep―24 |
Diversity of ACE2 and its interaction with SARS-CoV-2 receptor binding domain |
Jessie L Gan, Ruiqi Huang, Abigail Kelley, Gabrielle Warner, Duncan McGregor, Vaughn V. Smider |
| 34 |
[GO] |
Bioscience Reports |
2021―Sep―14 |
Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs |
Min Thura, Joel Xuan En Sng, Koon Hwee Ang, Jie Li, Abhishek Gupta, Jimmy Ming Hong, Cheng William Hong, Qi Zeng |
| 35 |
[GO] |
The Biochemist |
2021―Aug―23 |
Crowd sourcing yeast and rising above the pandemic: the SuperYeast project survival tale |
Naomi Wilkinson |
| 36 |
[GO] |
Biochemical Journal |
2021―Aug―13 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease |
Berta Canal, Allison W. McClure, Joseph F. Curran, Mary Wu, Rachel Ulferts, Florian Weissmann, Jingkun Zeng, Agustina P. Bertolin, Jennifer C. Milligan, Souradeep Basu, Lucy S. Drury, Tom D. Deegan, Ryo Fujisawa, Emma L. Roberts, Clovis Basier, Karim Labib, Rupert Beale, Michael Howell, John F.X. Diffley |
| 37 |
[GO] |
Bioscience Reports |
2021―Aug―05 |
Obesity, a major risk factor for immunity and severe outcomes of COVID-19 |
Mohammad Tohidul Amin, Kaniz Fatema, Sayama Arefin, Fahad Hussain, Dipty Rani Bhowmik, Mohammad Salim Hossain |
| 38 |
[GO] |
Biochemical Society Transactions |
2021―Aug―05 |
Host ADP-ribosylation and the SARS-CoV-2 macrodomain |
Nicolas C. Hoch |
| 39 |
[GO] |
Clinical Science |
2021―Aug―02 |
Role of ACE2 in pregnancy and potential implications for COVID-19 susceptibility |
Nayara Azinheira Nobrega Cruz, Danielle Stoll, Dulce Elena Casarini, Mariane Bertagnolli |
| 40 |
[GO] |
Bioscience Reports |
2021―Jul―30 |
SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 |
Lize M Grobbelaar, Chantelle Venter, Mare Vlok, Malebogo Ngoepe, Gert J Laubscher, Petrus J Lourens, Janami Steenkamp, Douglas Kell, Etheresia Pretorius |
| 41 |
[GO] |
Essays in Biochemistry |
2021―Jul―30 |
Roles of steroid receptors in the lung and COVID-19 |
Damien A. Leach, Greg N. Brooke, Charlotte L. Bevan |
| 42 |
[GO] |
Bioscience Reports |
2021―Jul―27 |
A lipidomic view of SARS-CoV-2 |
Kourosh Honarmand Ebrahimi, James McCullagh |
| 43 |
[GO] |
Bioscience Reports |
2021―Jul―22 |
Biochemical composition, transmission and diagnosis of SARS-CoV-2 |
Rajesh Ahirwar, Sonu Gandhi, Komal Komal, Geeta Dhaniya, Prem Prakash Tripathi, Vyas Madhavrao Shingatgeri, Krishan Kumar, Jai Gopal Sharma, Saroj Kumar |
| 44 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Author's overview: identifying SARS-CoV-2 antiviral compounds |
John F.X. Diffley |
| 45 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease |
Chew Theng Lim, Kang Wei Tan, Mary Wu, Rachel Ulferts, Lee A. Armstrong, Eiko Ozono, Lucy S. Drury, Jennifer C. Milligan, Theresa U. Zeisner, Jingkun Zeng, Florian Weissmann, Berta Canal, Ganka Bineva-Todd, Michael Howell, Nicola O'Reilly, Rupert Beale, Yogesh Kulathu, Karim Labib, John F.X. Diffley |
| 46 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase |
Souradeep Basu, Tiffany Mak, Rachel Ulferts, Mary Wu, Tom Deegan, Ryo Fujisawa, Kang Wei Tan, Chew Theng Lim, Clovis Basier, Berta Canal, Joseph F. Curran, Lucy S. Drury, Allison W. McClure, Emma L. Roberts, Florian Weissmann, Theresa U. Zeisner, Rupert Beale, Victoria H. Cowling, Michael Howell, Karim Labib, John F.X. Diffley |
| 47 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase |
Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, Viktor Posse, Berta Canal, Rachel Ulferts, Mary Wu, Ruth Harvey, Saira Hussain, Jennifer C. Milligan, Chloe Roustan, Annabel Borg, Laura McCoy, Lucy S. Drury, Svend Kjaer, John McCauley, Michael Howell, Rupert Beale, John F.X. Diffley |
| 48 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase |
Agustina P. Bertolin, Florian Weissmann, Jingkun Zeng, Viktor Posse, Jennifer C. Milligan, Berta Canal, Rachel Ulferts, Mary Wu, Lucy S. Drury, Michael Howell, Rupert Beale, John F.X. Diffley |
| 49 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease |
Jennifer C. Milligan, Theresa U. Zeisner, George Papageorgiou, Dhira Joshi, Christelle Soudy, Rachel Ulferts, Mary Wu, Chew Theng Lim, Kang Wei Tan, Florian Weissmann, Berta Canal, Ryo Fujisawa, Tom Deegan, Hema Nagaraj, Ganka Bineva-Todd, Clovis Basier, Joseph F. Curran, Michael Howell, Rupert Beale, Karim Labib, Nicola O'Reilly, John F.X. Diffley |
| 50 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp15 endoribonuclease |
Berta Canal, Ryo Fujisawa, Allison W. McClure, Tom D. Deegan, Mary Wu, Rachel Ulferts, Florian Weissmann, Lucy S. Drury, Agustina P. Bertolin, Jingkun Zeng, Rupert Beale, Michael Howell, Karim Labib, John F.X. Diffley |
| 51 |
[GO] |
Biochemical Journal |
2021―Jul―01 |
An all-out assault on SARS-CoV-2 replication |
Ronald T. Hay |
| 52 |
[GO] |
Bioscience Reports |
2021―Jul―01 |
Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 |
Aline H de Nooijer, Inge Grondman, Simon Lambden, Emma J Kooistra, Nico AF Janssen, Matthijs Kox, Peter Pickkers, Leo AB Joosten, Frank van de Veerdonk, Marc Derive, Sebastien Gibot, Mihai G Netea |
| 53 |
[GO] |
Bioscience Reports |
2021―Jun―16 |
Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy |
Safa Kinaneh, Iyad Khamaysi, Tony Karram, Shadi Hamoud |
| 54 |
[GO] |
Essays in Biochemistry |
2021―Mai―24 |
3D Bioprinting for fabrication of tissue models of COVID-19 infection |
Anisha Kabir, Pallab Datta, Julia Oh, Adam Williams, Veli Ozbolat, Derya Unutmaz, Ibrahim T. Ozbolat |
| 55 |
[GO] |
Clinical Science |
2021―Apr―21 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat? |
Fedor Simko, Tomas Baka |
| 56 |
[GO] |
The Biochemist |
2021―Apr―09 |
The COVID-19 pandemic: impact on the molecular bioscience research community and beyond |
Pedro Ferreira, Dominika Gruszka, Derry Mercer |
| 57 |
[GO] |
Biochemical Society Transactions |
2021―Mrz―05 |
Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter? |
Devanshi Mishra, Chinmoy Sankar Dey |
| 58 |
[GO] |
Bioscience Reports |
2021―Feb―26 |
Lipidomic Alteration of Plasma in Cured COVID-19 Patients using UltraHigh-Performance Liquid Chromatography with High-Resolution Mass Spectrometry |
Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, Yuemei He, Linhui Hu, Chunbo Chen |
| 59 |
[GO] |
Bioscience Reports |
2021―Feb―24 |
Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates |
Mateus S.M. Serafim, Jadson C. Gertrudes, Débora M. A. Costa, Patricia R. Oliveira, Vinicius G. Maltarollo, Kathia Maria Honorio |
| 60 |
[GO] |
Bioscience Reports |
2021―Feb―24 |
The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage |
Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang |
| 61 |
[GO] |
Bioscience Reports |
2021―Feb―23 |
Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 |
|
| 62 |
[GO] |
Clinical Science |
2021―Feb―06 |
ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders |
Xi Cao, Li-Ni Song, Jin-Kui Yang |
| 63 |
[GO] |
Clinical Science |
2021―Jan―29 |
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease |
Jithin Kuriakose, Augusto C. Montezano, Rhian M. Touyz |
| 64 |
[GO] |
Clinical Science |
2021―Jan―23 |
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19 |
Maria A Pedrosa, Rita Valenzuela, Pablo Garrido, Carmen M Labandeira, Gemma Navarro, Rafael Franco, Jose Luis Labandeira-Garcia, Ana I Rodriguez-Perez |
| 65 |
[GO] |
Bioscience Reports |
2021―Jan―23 |
Hyperglycaemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: A meta-analysis |
Yan Yang, Zixin Cai, Jingjing Zhang |
| 66 |
[GO] |
Bioscience Reports |
2021―Jan―14 |
ACE/ACE2 balance might be instrumental to explain the certain comorbidities lead to severe COVID-19 cases |
Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan |
| 67 |
[GO] |
Biochemical Journal |
2021―Jan―14 |
The role of chemical biology in the fight against SARS-CoV-2 |
George M. Burslem |
| 68 |
[GO] |
Clinical Science |
2021―Jan―07 |
Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases |
Ravindra K. Sharma, Jing Li, Suraj Krishnan, Elaine M. Richards, Mohan K. Raizada, Rajesh Mohandas |
| 69 |
[GO] |
Biochemical Society Transactions |
2020―Dez―24 |
Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies |
Ilaria Manfredonia, Danny Incarnato |
| 70 |
[GO] |
Bioscience Reports |
2020―Dez―22 |
Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 |
Guolian Zhao, Yazhou Xu, Jing Li, Xiaoli Cui, Xiaowen Tan, Hongyue Zhang, Liyun Dang |
| 71 |
[GO] |
The Biochemist |
2020―Dez―12 |
Uncloaking the invisible killer and developing an antidote to SARS-CoV-2 |
Andre Watson |
| 72 |
[GO] |
Clinical Science |
2020―Dez―11 |
ACE2, a multifunctional protein - from cardiovascular regulation to COVID-19 |
Michael Bader, Anthony J. Turner, Natalia Alenina |
| 73 |
[GO] |
Bioscience Reports |
2020―Dez―11 |
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential |
Zubair A Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, Mohamed Halawa, Kenton P Arkill, Andrew Jackson, David O. Bates, Jonas Elmsley |
| 74 |
[GO] |
Clinical Science |
2020―Dez―09 |
ACE2: from protection of liver disease to propagation of COVID-19 |
Fiona J. Warner, Harinda Rajapaksha, Nicholas Shackel, Chandana B. Herath |
| 75 |
[GO] |
The Biochemist |
2020―Dez―09 |
Teaching and learning biochemistry in a pandemic (and beyond?) |
Chris Willmott |
| 76 |
[GO] |
Emerging Topics in Life Sciences |
2020―Dez―03 |
How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far |
Sumana Sanyal |
| 77 |
[GO] |
Clinical Science |
2020―Dez―03 |
Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists |
U. Muscha Steckelings, Colin Sumners |
| 78 |
[GO] |
Emerging Topics in Life Sciences |
2020―Dez―01 |
The zoonotic potential of bat-borne coronaviruses |
Ny Anjara Fifi Ravelomanantsoa, Sarah Guth, Angelo Andrianiaina, Santino Andry, Anecia Gentles, Hafaliana Christian Ranaivoson, Cara E. Brook |
| 79 |
[GO] |
Biochemical Society Transactions |
2020―Dez―01 |
A pocket guide on how to structure SARS-CoV-2 drugs and therapies |
Dene R. Littler, Bruce J. MacLachlan, Gabrielle M. Watson, Julian P. Vivian, Benjamin S. Gully |
| 80 |
[GO] |
Bioscience Reports |
2020―Nov―30 |
Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical |
Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang |
| 81 |
[GO] |
Clinical Science |
2020―Nov―25 |
ACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19 |
Koichi Yamamoto, Hikari Takeshita, Hiromi Rakugi |
| 82 |
[GO] |
Emerging Topics in Life Sciences |
2020―Nov―17 |
Endothelial pulsatile shear stress is a backstop for COVID-19 |
Marvin A. Sackner, Jose A. Adams |
| 83 |
[GO] |
Bioscience Reports |
2020―Nov―17 |
Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. |
Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, Federico Braglia-Orlandini, Daniele Turini, Vittoria Guarinoni, Michele Saottini, Sara Viola, Giulia Ferrari-Toninelli, Giancarlo Pasini, Cristina Mascadri, Bianca Bonzi, Paolo Desenzani, Claudia Tusi, Eros Zanotti, Matteo Nardin, Damiano Rizzoni |
| 84 |
[GO] |
Biochemical Society Transactions |
2020―Nov―10 |
Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications |
Jiayue-Clara Jiang, Yan Zhang |
| 85 |
[GO] |
Bioscience Reports |
2020―Nov―04 |
Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 |
Chun Liang, Wenhao Niu, Feng Wu, Wenyue Cao, Zonggui Wu, Yu Chieh Chao, Fei Peng |
| 86 |
[GO] |
Clinical Science |
2020―Nov―04 |
ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV |
Lizelle Lubbe, Gyles E. Cozier, Delia Oosthuizen, K. Ravi Acharya, Edward D. Sturrock |
| 87 |
[GO] |
Clinical Science |
2020―Nov―02 |
ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery |
Enrique Lores, Jan Wysocki, Daniel Batlle |
| 88 |
[GO] |
Biochemical Society Transactions |
2020―Okt―21 |
Transmission and prevention of SARS-CoV-2 |
Zhongyi Wang, Yingying Fu, Zhendong Guo, Jiaming Li, Jingjing Li, Hongliang Cheng, Bing Lu, Qiang Sun |
| 89 |
[GO] |
Bioscience Reports |
2020―Okt―16 |
Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide? |
Abdulla A-B Badawy |
| 90 |
[GO] |
Clinical Science |
2020―Okt―16 |
Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease |
Carlos M. Ferrario, Sarfaraz Ahmad, Leanne Groban |
| 91 |
[GO] |
The Biochemist |
2020―Okt―12 |
Understanding the impact of COVID-19 on early career molecular bioscientists |
Dominika Gruszka |
| 92 |
[GO] |
Clinical Science |
2020―Sep―29 |
Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19 |
Nigel M. Hooper, Daniel W. Lambert, Anthony J. Turner |
| 93 |
[GO] |
Clinical Science |
2020―Sep―09 |
Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission |
|
| 94 |
[GO] |
Clinical Science |
2020―Sep―01 |
Using serpins cysteine protease cross-specificity to possibly trap SARS-CoV-2 Mpro with reactive center loop chimera |
Mohamad Aman Jairajpuri, Shoyab Ansari |
| 95 |
[GO] |
Clinical Science |
2020―Aug―21 |
Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission |
Daniella S. Battagello, Guilherme Dragunas, Marianne O. Klein, Ana L.P. Ayub, Fernando J. Velloso, Ricardo G. Correa |
| 96 |
[GO] |
Clinical Science |
2020―Aug―04 |
Suppressed anti-inflammatory heat shock response in high-risk COVID-19 patients: lessons from basic research (inclusive bats), light on conceivable therapies |
Thiago Gomes Heck, Mirna Stela Ludwig, Matias Nunes Frizzo, Alberto Antonio Rasia-Filho, Paulo Ivo Homem de Bittencourt |
| 97 |
[GO] |
Bioscience Reports |
2020―Jul―29 |
Blood routine test in mild and common 2019 coronavirus (COVID-19) patients |
Dodji Kossi Djakpo, Zhiquan Wang, Rong Zhang, Xin Chen, Peng Chen, Malyn Martha Lilac ketisha Antoine |
| 98 |
[GO] |
Clinical Science |
2020―Jun―16 |
Decoy ACE2-expressing extracellular vesicles that competitively bind SARS-CoV-2 as a possible COVID-19 therapy |
Jameel M. Inal |
| 99 |
[GO] |
Clinical Science |
2020―Jun―16 |
SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure |
Alain R. Thierry, Benoit Roch |
| 100 |
[GO] |
Biochemical Society Transactions |
2020―Jun―08 |
α-glucosidase inhibitors as host-directed antiviral agents with potential for the treatment of COVID-19 |
Spencer J. Williams, Ethan D. Goddard-Borger |
| 101 |
[GO] |
Clinical Science |
2020―Jun―08 |
Covid-19: the renin-angiotensin system imbalance hypothesis |
Katharina Lanza, Lucas G. Perez, Larissa B. Costa, Thiago M. Cordeiro, Vitria A. Palmeira, Victor T. Ribeiro, Ana Cristina Simões e Silva |
| 102 |
[GO] |
Bioscience Reports |
2020―Mai―22 |
Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 |
Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Alajmi, Afzal Hussain, Md. Tabish Rehman, Asimul Islam, Md. Imtaiyaz Hassan |
| 103 |
[GO] |
Clinical Science |
2020―Mai―22 |
Alternative splicing of ACE2 possibly generates variants that may limit the entry of SARS-CoV-2: a potential therapeutic approach using SSOs |
Sayeed ur Rehman, Mohammad Tabish |
| 104 |
[GO] |
Bioscience Reports |
2020―Mai―07 |
A virus that has gone viral: Amino-acid mutation in S protein of Indian-isolate of Coronavirus COVID-19 might impact receptor-binding, thus infectivity |
Priyanka Saha, Arup Kumar Banerjee, Prem Prakash Tripathi, Amit Kumar Srivastava, Upasana Ray |
| 105 |
[GO] |
Biochemical Journal |
2020―Apr―29 |
Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle |
Samantha Gildenhuys |
| 106 |
[GO] |
Clinical Science |
2020―Apr―07 |
ACE2 the Janus-faced protein - from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19 |
Rhian M. Touyz, Hongliang Li, Christian Delles |
| 107 |
[GO] |
Clinical Science |
2020―Mrz―13 |
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? |
Daniel Batlle, Jan Wysocki, Karla Satchell |
| 108 |
[GO] |
Biochemical Journal |
2020―Feb―21 |
Processing of the SARS-CoV pp1a/ab nsp7-10 region |
Boris Krichel, Sven Falke, Rolf Hilgenfeld, Lars Redecke, Charlotte Uetrecht |
